HeyJaredCancerCast
New scientific developments are transforming the future of cancer treatment and care. Hosted by world-renowned medical oncologist Dr. Manish Shah, CancerCast is your window into research breakthroughs, innovative therapies, and honest accounts of living with and beyond cancer.
- Indexed episodes, last 90 days
- 3
- Latest publication
- Sep 23, 2026
- Audience
- Checking…
- Earliest in this view
- Jul 31, 2026
Latest episodes
GLP-1s and Cancer: Popular Weight Loss Drugs Go Beyond The Scale (opens the original)
Read excerpt
GLP-1 (short for glucagon-like peptide-1) medications such as semaglutide (Ozempic and Wegovy) and tirzepatide (Mounjaro and Zepbound) have transformed the treatment of obesity and type 2 diabetes. These drugs mimic naturally occurring peptide hormones in the body that help regulate appetite, blood sugar, and metabolism. Because these drugs are so effective and new research is uncovering additional benefits beyond blood sugar control and weight loss, these drugs are increasing in popularity and
A Breakthrough in Pancreatic Cancer Treatment – KRAS Targeting and Daraxonrasib (opens the original)
Read excerpt
Pancreatic cancer treatment has entered an exciting new chapter. On August 26, 2026, the U.S. Food and Drug Administration (FDA) approved the oral medication daraxonrasib for metastatic pancreatic cancer. This represents a breakthrough in pancreatic cancer treatment. It is the first ever RAS-targeted therapy for metastatic pancreatic cancer and the first major new metastatic pancreatic cancer treatment that has been approved this decade. In this episode of CancerCast, Drs. Manish Shah and Shubha
ASCO 2026 Highlights (opens the original)
Read excerpt
The American Society of Clinical Oncology, or ASCO, Annual Meeting is the world’s largest oncology conference. The meeting brings together cancer experts, thought leaders and professionals from around the world to present groundbreaking research that is changing patient care and moving the field forward. Drs. Manish Shah and David Nanus discuss some of the most impactful research presented at the 2026 ASCO Annual Meeting. They explore practice-changing advances across a wide range of cancer type
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.